Eckert & Ziegler Strahlen- und Medizintechnik AG Stock OTC Markets

Equities

EKZRF

DE0005659700

Office Equipment

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Eckert & Ziegler Strahlen- und Medizintechnik AG -.--% -.--%

Financials

Sales 2024 * 271M 294M 401M Sales 2025 * 296M 322M 438M Capitalization 952M 1.03B 1.41B
Net income 2024 * 34M 36.87M 50.25M Net income 2025 * 36M 39.04M 53.2M EV / Sales 2024 * 3.35 x
Net cash position 2024 * 43.4M 47.07M 64.14M Net cash position 2025 * 42.6M 46.2M 62.95M EV / Sales 2025 * 3.07 x
P/E ratio 2024 *
27.5 x
P/E ratio 2025 *
25.8 x
Employees -
Yield 2024 *
1.1%
Yield 2025 *
1.1%
Free-Float 67.02%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Eckert & Ziegler Strahlen- und Medizintechnik AG

Managers TitleAgeSince
Chief Executive Officer 57 16-12-31
Founder 55 96-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 71 18-12-31
Founder 55 96-12-31
Director/Board Member 71 19-05-28
More insiders
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.66 EUR
Average target price
62.5 EUR
Spread / Average Target
+36.88%
Consensus

Annual profits - Rate of surprise